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Changes in the ankle-brachial index (ABI) and progression to
peripheral arterial disease (PAD) may result in major detrimental
effects on quality of life and functional status and, more impor-
tantly, are potent predictors of myocardial infarction, stroke, and
death. Despite its frequent occurrence, little is known about the
natural history of PAD among minority ethnic groups.
The Multi-Ethnic Study of Atherosclerosis (MESA) was de-
signed to determine ethnic differences in the progression of sub-
clinical to clinical cardiovascular disease.
In the current study, Allison et al assessed changes in ABI in
the MESA cohort over a 3-year time period. The authors conclude
that besides traditional risk factors, African Americans had a signif-
icantly higher risk of progression to a low ABI (0.9) and a
reduced trend towards progression to a high ABI (1.4). Con-
versely, Hispanics and Chinese did not reveal significant changes in
ABI over time. These findings should not come as a surprise as
African Americans have repeatedly been shown to have a higher
prevalence of PAD, which appears independent of both traditional
and novel vascular risk factors. There are, however, several uncer-
tainties and ambiguities that deserve further investigation.
Although PAD has traditionally been defined as resting ABI of
less than 0.90, the ABI may underestimate the severity of disease in
individuals with calcified, noncompressible arteries, which areadvanced age. Although the literature quoted by most epidemio-
logic studies, including this one, regarding the accuracy of the ABI
to detect PAD is primarily based in small clinical observational
studies that assessed individuals with established PAD prior to
treatment, the ABI has been accepted without adequate scrutiny in
all populations, including those with high prevalence of diabetes.
In the MESA cohort, Hispanics did not have an increased risk of
significant ABI changes despite similar age and sex-adjusted prev-
alence of baseline diabetes and dyslipidemia compared with African
Americans. Allison et al claim that the stability of ABI among
Hispanics may be related to either no actual changes or similar
progression in atherosclerosis and arterial rigidity. If one assumes
that, as suggested by the authors, progression is the rule, the lack of
changes in ABI may be more likely related to progression of both
atherosclerosis and arterial rigidity. It may also mean that among
Hispanics, there may be individuals with either baseline or subse-
quent stenosis of 50% or more in a major leg artery, ie, PAD, that
may not result in lower ABI because of the “compensatory”
increased arterial rigidity. The ABImay, therefore, be inaccurate to
detect PAD in Hispanics given their high prevalence of diabetes
and vascular calcification that render the ABI unreliable. Other
noninvasive tests, such as pulse volume recordings and toe-brachial
index, in addition to the ABI, should be assessed for accurate
detection and screening of PAD in this defined population.
